4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020384
Chief Business Officer sold 2,283 shares at $8.06 ($18,401)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luu Brendan Chief Business Officer | 2024-12-06 | Sale 10b5-1 | −2,283 | $8.06 | $18,401 | 36,047 | D |
| Open-market sales · 2,283 sh · avg $8.06 · $18,401 | |||||||
Loading xslF345X05/form4.xml…